Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease

Journal of Clinical Oncology

Volumn 25, Issue 3, 2007, Pages 332-337

  Donaldson, Sarah S ^a   Link, Michael P ^a   Weinstein, Howard J ^a   Rai, Shesh N ^a   Brain, Sam ^a   Billett, Amy L ^a   Hurwitz, Craig A ^a   Krasin, Matthew ^a   Kun, Larry E ^a   Marcus, Karen C ^a   Tarbell, Nancy J ^a   Young, Jeffrey A ^a   Hudson, Melissa M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; METHOTREXATE; PREDNISONE; VINBLASTINE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EWING SARCOMA; FEMALE; FOLLOW UP; HEART DISEASE; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SYMPTOM; THYROID CANCER; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PRESCHOOL CHILD; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; MALE; METHOTREXATE; PREDNISONE; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 33846903567     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.4772     Document Type: Article

References (20)

1. Donaldson SS, Hudson MM, Lamborn KR, et al: VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial. J Clin Oncol 20:3081-3087, 2002
2. Donaldson SS, Link MP: Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol 5:742-749, 1987
3. Hunger SP, Link MP, Donaldson SS: Long-term results of ABVD/MOPP and low dose involved field radiotherapy in pediatric Hodgkin's disease. J Clin Oncol 12:2160-2168, 1994
4. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861, 1971
5. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
6. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
7. Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:650-653, 1965
8. Dorffel W, Luders H, Ruhl U, et al: Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: Analysis and outlook. Klin Padiatr 215:139-145, 2003
9. Nachman JB, Sposto R, Herzog P, et al: Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy J Clin Oncol 20:3765-3771, 2002
10. Schellong G, Bramswig JH, Hornig-Franz I, et al: Hodgkin's disease in children: Combined modality treatment for stages IA, IB, and IIA - results in 356 patients of the German/Austrian Pediatric Study Group. Ann Oncol 5:113-115, 1994
11. Schellong G, Hornig-Franz I, Rath B, et al: Reducing radiotherapy dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood: A report of the cooperative DAL-HD-87 study. Klin Padiatr 206:253-262, 1994
12. Landman-Parker J, Pacquement H, Lebanc T, et al: Localized childhood Hodgkin's disease: Response adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low dose radiation therapy: Results of the French Society of Pediatric Oncology study MDH90. J Clin Oncol 18:1500-1507, 2000
13. Pedrick TJ, Hoppe RT: Recovery of spermatogenesis following pelvic irradiation for Hodgkin's disease. Int J Radiat Oncol Biol Phys 12:117, 1986
14. Griffin JE, Wilson JD: Disorders of the testes and the male reproductive tract, in Wilson JD, Foster DW (eds): Williams Textbook of Endocrinology. Philadelphia, PA, WB Saunders, 1992, pp 799-852
15. Metzger ML, Hudson MM, Somes GW, et al: White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's lymphoma. J Clin Oncol 24:1516-1521, 2006
16. Sorensen K, Levitt GA, Bull C, et al: Late anthracycline cardiotoxicity after childhood cancer: A prospective longitudinal study. Cancer 97:1991-1998, 2003
17. Children's Oncology Group: Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers. www.survivorshipguidelines.org
18. Landier W, Bhatia S, Eshelman DA, et al: Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group long-term follow-up guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22:4979-4990, 2004
19. Merchant TE, Nguyen L, Nguyen D, et al: Differential attenuation of clavicle growth after asymmetric mantle radiotherapy. Int J Radiat Oncol Biol Phys 59:556-561, 2004
20. Mauch P, Goodman R, Hellman S: The significance of mediastinal involvement in early-stage Hodgkin's disease. Cancer 42:1039-1045, 1978